Market Overview
| Study Period | 2020 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Market Size (2025) | USD 90.30 Billion |
| Market Size (2030) | USD 109.44 Billion |
| Growth Rate (2025 - 2030) | 3.92% CAGR |
| Market Concentration | Low |
Major Players*Disclaimer: Major Players sorted in no particular order Image © Mordor Intelligence. Reuse requires attribution under CC BY 4.0. |
|
Europe Pharmaceutical Logistics Market Analysis
The Europe Pharmaceutical Logistics Market size is estimated at USD 90.30 billion in 2025, and is expected to reach USD 109.44 billion by 2030, at a CAGR of 3.92% during the forecast period (2025-2030).
The European pharmaceutical logistics sector continues to demonstrate robust development, underpinned by substantial research and development investments. The industry invested EUR 44,500 million in R&D during 2022, highlighting its commitment to innovation and technological advancement. This investment has created significant employment opportunities, with the sector directly employing approximately 865,000 people while generating three times as many indirect jobs throughout the pharmaceutical supply chain. The increasing focus on research and development has led to the emergence of specialized logistics requirements, particularly in handling temperature-sensitive medications and biological products.
Supply chain modernization has become a central focus for pharmaceutical logistics providers across Europe, with companies implementing advanced technological solutions to enhance operational efficiency. Logistics companies are increasingly adopting automation technologies, artificial intelligence, and predictive optimization software to streamline operations. The integration of smart packaging solutions offering complete traceability and accurate shipping tracking has become standard practice, with real-time temperature monitoring and blockchain technology ensuring product integrity throughout the pharmaceutical delivery process.
The European pharmaceutical logistics landscape is experiencing a significant shift toward sustainability and environmental responsibility. Major logistics providers are investing in green technologies and sustainable transportation solutions to reduce their carbon footprint. Companies are developing strategic solutions to optimize their networks, with many establishing additional international hubs and service centers across Europe to enhance distribution efficiency. The industry has witnessed a notable trend toward the consolidation of cold chain infrastructure, with several companies establishing European-wide networks of temperature-controlled facilities, enhancing the pharmaceutical cold chain.
Cross-border pharmaceutical distribution continues to strengthen Europe's position as a global logistics hub, with Belgium alone accounting for one-sixth of all medicines exported from Europe. The pharmaceutical logistics network has evolved to accommodate increasing international trade volumes, with strategic investments in port facilities and transportation infrastructure. Major European ports, particularly in Belgium and the Netherlands, have developed specialized pharmaceutical handling capabilities, with Antwerp's port becoming the first globally to implement rigorous GDP (Good Distribution Practice) standards throughout its supply chain. The industry has seen significant expansion in cold chain capacity, with new facilities being established to handle the growing volume of temperature-sensitive pharmaceutical products.
Europe Pharmaceutical Logistics Market Trends
Growing Pharmaceutical Industry and Export Activities
The robust growth of Europe's pharmaceutical manufacturing and export activities is serving as a primary driver for the pharmaceutical supply market. This is evidenced by Germany's remarkable export growth from EUR 50 billion in 2002 to EUR 287 billion in 2022, representing a 22% increase from 2021 alone. The presence of over 510 pharmaceutical companies and 670 biotech companies across Europe has created an extensive network requiring sophisticated logistics solutions, particularly as these companies focus on developing increasingly complex products such as biosimilars and biological medicines. The industry's commitment to innovation is further demonstrated by substantial investments in research and development, with Belgian pharmaceutical companies alone investing over EUR 1.5 billion in R&D activities.
The expansion of pharmaceutical manufacturing capabilities has led to increased demand for specialized logistics services that can handle high-value pharmaceutical products. The industry's focus has shifted towards developing complex biological-based medicines, hormone treatments, vaccines, and intricate protein formulations, all requiring specialized transportation and warehousing solutions. This evolution in pharmaceutical product complexity has necessitated the development of more sophisticated logistics networks capable of maintaining product integrity throughout the supply chain, from manufacturing facilities to end-users.
Understand The Key Trends Shaping This Market
Download PDF
Advanced Cold Chain Infrastructure Development
The increasing complexity of pharmaceutical products has driven significant investments in pharmaceutical cold chain infrastructure across Europe. Logistics providers are developing specialized solutions to handle various temperature requirements, from standard 2-8°C refrigeration to ultra-low temperature storage at -70°C for sensitive biologics. The industry has witnessed substantial investments in temperature-controlled warehouses, specialized transportation fleets, and monitoring systems to ensure product integrity throughout the supply chain. For instance, major logistics hubs like Frankfurt Airport have developed the world's largest temperature-controlled infrastructure, serving more than 180 destinations and handling approximately 120,000 tons of pharmaceuticals annually.
The strategic evolution of cold chain logistics has led to the implementation of sophisticated temperature monitoring and control systems across the supply chain. Logistics providers are investing in advanced technologies such as real-time temperature monitoring, automated alert systems, and specialized packaging solutions to maintain required temperature ranges during transit. This infrastructure development extends beyond just storage facilities to include specialized vehicles, loading docks, and handling equipment designed specifically for temperature-sensitive pharmaceutical products. The industry has also witnessed the emergence of dedicated pharmaceutical logistics parks and specialized warehousing facilities equipped with multiple temperature zones to accommodate different product requirements.
Strategic Geographical Positioning and Infrastructure Networks
Europe's strategic geographical position has emerged as a crucial driver for pharmaceutical logistics operations, supported by its extensive transportation infrastructure and interconnected networks. The region's advanced transportation infrastructure includes over 250 inland ports, 25 international airports, and approximately 40,000 kilometers of railway tracks, facilitating efficient multimodal pharmaceutical transportation of pharmaceutical products. This comprehensive network enables logistics providers to optimize routes and delivery times while maintaining the strict temperature and handling requirements necessary for pharmaceutical products. The strategic location also allows for efficient distribution to both domestic European markets and international destinations.
The development of specialized pharmaceutical logistics hubs at major transportation nodes has further enhanced the region's capabilities. These hubs feature integrated facilities for storage, handling, and distribution, often incorporating multiple transportation modes to ensure flexible and efficient delivery options. For instance, the port of Antwerp has established itself as a central hub for pharmaceutical logistics, offering GDP-compliant warehousing facilities with both refrigerated and room-temperature storage capabilities. The integration of different transportation modes - air, sea, rail, and road - allows for optimized routing and reduced transit times, crucial for temperature-sensitive pharmaceutical products.
Technological Integration and Automation Advancement
The pharmaceutical logistics sector is experiencing a significant transformation driven by the integration of advanced technologies and automation solutions. From last-mile delivery robots to automated picking systems and predictive optimization software, artificial intelligence is revolutionizing logistics operations across Europe. These technological advancements have enabled more efficient warehouse operations, improved tracking capabilities, and enhanced temperature monitoring systems, all crucial for maintaining pharmaceutical product integrity. The implementation of these technologies has resulted in improved operational efficiency, reduced human error, and enhanced compliance with regulatory requirements.
The industry has witnessed widespread adoption of sophisticated tracking and monitoring systems that provide real-time visibility throughout the supply chain. Advanced sensor technologies, combined with Internet of Things (IoT) connectivity, enable continuous monitoring of temperature, humidity, and other critical parameters during storage and transit. For instance, major logistics providers have implemented systems capable of providing real-time temperature data and automated alerts, ensuring immediate response to any deviations from required storage conditions. These technological solutions also facilitate better documentation and reporting capabilities, essential for maintaining compliance with Good Distribution Practice (GDP) requirements and other regulatory standards.
Segment Analysis: By Product
Branded Drugs Segment in Europe Pharmaceutical Logistics Market
The Branded Drugs segment maintains its dominant position in the European pharmaceutical logistics market, commanding approximately 56% of the market share in 2024. This segment's prominence is driven by the strong presence of major pharmaceutical companies and their established distribution networks across Europe. The segment benefits from hospitals' and physicians' continued preference for branded medications, particularly for complex therapeutic areas and specialized treatments. The robust research and development infrastructure in European countries, especially in Germany, Switzerland, and the UK, further strengthens this segment's market position. Additionally, the segment's growth is supported by increasing investments in pharmaceutical cold chain logistics infrastructure specifically designed for handling temperature-sensitive branded biologics and specialty pharmaceuticals.
Generic Drugs Segment in Europe Pharmaceutical Logistics Market
The Generic Drugs segment is experiencing the fastest growth in the European pharmaceutical logistics market, with a projected growth rate of approximately 4% from 2024 to 2029. This accelerated growth is primarily driven by increasing government initiatives to promote generic drug usage and reduce healthcare costs across European nations. The segment's expansion is further supported by the implementation of favorable policies and regulatory frameworks that streamline the approval process for generic medications. The growth is also bolstered by the rising demand for cost-effective pharmaceutical solutions, particularly in emerging European markets. Logistics companies are increasingly investing in specialized distribution networks and storage facilities to handle the growing volume of generic pharmaceuticals while maintaining compliance with Good Distribution Practice (GDP) guidelines. The role of pharmaceutical transportation is crucial in ensuring these generic drugs reach their destinations efficiently.
Segment Analysis: By Mode of Operation
Non-cold Chain Logistics Segment in European Pharmaceutical Logistics Market
The non-cold chain logistics segment dominates the European pharmaceutical logistics market, accounting for approximately 64% of the total market share in 2024. This segment primarily handles pharmaceutical products that can be stored and transported at room temperature without requiring specialized temperature-controlled environments. The segment's prominence is driven by the large volume of generic medications, over-the-counter drugs, and certain branded pharmaceuticals that don't require strict temperature control. The robust infrastructure for non-cold chain logistics across Europe, including extensive warehouse networks and established transportation routes, further strengthens this segment's market position. Major logistics providers have invested significantly in expanding their non-cold chain capabilities, implementing advanced tracking systems, and ensuring GDP (Good Distribution Practice) compliance to maintain product integrity throughout the supply chain.
Cold Chain Logistics Segment in European Pharmaceutical Logistics Market
The cold chain logistics segment is experiencing the fastest growth in the European pharmaceutical logistics market, with a projected growth rate of approximately 4% during 2024-2029. This accelerated growth is primarily driven by the increasing development and distribution of temperature-sensitive biopharmaceuticals, vaccines, and other specialized medications requiring precise temperature control. The expansion of personalized medicine and the growing emphasis on maintaining product efficacy through stringent temperature monitoring have further catalyzed the segment's growth. Logistics providers are increasingly investing in advanced cold chain infrastructure, including temperature-controlled warehouses, specialized transportation vehicles, and sophisticated monitoring systems. The implementation of IoT-enabled temperature monitoring devices and blockchain technology for end-to-end visibility has significantly enhanced the reliability and efficiency of pharma cold chain operations across Europe. The importance of vaccine logistics has also amplified the need for robust pharmaceutical cold chain solutions.
Segment Analysis: By Application
Chemical Pharma Segment in Europe Pharmaceutical Logistics Market
The Chemical Pharma segment dominates the European pharmaceutical logistics market, holding approximately 61% market share in 2024. This segment's strong position is driven by the extensive network of chemical pharmaceutical manufacturing facilities across Europe, particularly in countries like Germany, Switzerland, and France. The segment benefits from established distribution networks, specialized storage facilities, and temperature-controlled transportation systems designed specifically for chemical pharmaceuticals. Major logistics providers have invested significantly in GDP-compliant warehousing facilities and transportation solutions to meet the stringent requirements of chemical pharmaceutical products. The segment's growth is supported by increasing exports of chemical pharmaceutical products from European manufacturing hubs to global markets, with countries like Germany leading in chemical pharmaceutical exports. Additionally, the presence of numerous generic drug manufacturers and the growing demand for cost-effective pharmaceutical products continue to drive the chemical pharma logistics segment's dominance in the market.
Bio-Pharma Segment in Europe Pharmaceutical Logistics Market
The Bio-Pharma segment is emerging as the fastest-growing segment in the European pharmaceutical logistics market, with a projected growth rate of approximately 4% from 2024 to 2029. This growth is primarily driven by increasing investments in biopharmaceutical research and development across Europe, particularly in countries like Germany, France, and Switzerland. The segment's expansion is supported by the rising demand for specialized cold chain logistics solutions required for temperature-sensitive biological products. Logistics providers are increasingly investing in advanced cold chain infrastructure, including temperature-controlled warehouses and specialized transportation equipment, to meet the complex requirements of biopharmaceutical products. The growth is further accelerated by the expanding pipeline of biological drugs, vaccines, and personalized medicines requiring precise temperature-controlled logistics solutions. Additionally, the increasing adoption of biologics in treating various chronic diseases and the growing focus on precision medicine are creating new opportunities for specialized bio-pharma logistics services across Europe. The role of clinical trial logistics is also becoming significant in this segment.
Segment Analysis: By Mode of Transport
Road Shipping Segment in European Pharmaceutical Logistics Market
Road shipping continues to dominate the European pharmaceutical logistics market, commanding approximately 53% market share in 2024. This segment's prominence is driven by the geographic advantage of European countries being well-connected by roadways, making road freight an essential medium for pharmaceutical transportation. The segment benefits from extensive infrastructure development, technological implementation, and digitization efforts across the region. Road shipping offers unparalleled flexibility in terms of last-mile delivery capabilities and the ability to maintain consistent temperature control throughout the journey. The segment's strength is further enhanced by the presence of GDP-compliant networks and advanced cold-chain platforms that ensure pharmaceutical product integrity during transit. Major logistics providers have invested significantly in specialized vehicles equipped with temperature monitoring systems and real-time tracking capabilities to meet the stringent requirements of pharmaceutical shipping.
Rail Shipping Segment in European Pharmaceutical Logistics Market
The rail shipping segment is projected to experience the highest growth rate of approximately 5% during the forecast period 2024-2029. This growth is primarily attributed to increasing investments in rail infrastructure development and the implementation of new technologies to digitize rail freight operations. The segment is witnessing rising popularity due to its lower disruption rates and ability to provide cost-effective solutions for long-distance pharmaceutical transportation. Rail freight companies are continuously investing in improving their services, including increasing payload capacities and implementing sophisticated temperature control systems. The growth is further supported by the European Union's commitment to reducing greenhouse gas emissions, with several railroad companies signing agreements to cut emissions significantly. The segment is also benefiting from the development of new direct train connections and dedicated customer block trains, particularly in key pharmaceutical manufacturing and distribution hubs.
Remaining Segments in Transport Mode Market Segmentation
The air shipping and sea shipping segments complete the transport mode landscape in the European pharmaceutical logistics market. Air shipping plays a crucial role in the rapid transportation of high-value, time-sensitive pharmaceutical products, particularly for intercontinental routes and emergency medical supplies. The segment is characterized by stringent quality controls and specialized handling procedures at airports. Sea shipping, while slower, offers cost-effective solutions for bulk pharmaceutical transportation and has gained prominence due to its reliability and environmental sustainability. Both segments have witnessed significant developments in temperature-controlled containers and monitoring systems, with major ports and airports investing in pharmaceutical-specific infrastructure and handling facilities. These segments complement road and rail shipping by providing diverse options for pharmaceutical companies to optimize their supply chain strategies based on product requirements, urgency, and cost considerations.
Europe Pharmaceutical Logistics Market Geography Segment Analysis
Pharmaceutical Logistics Market in Germany
Germany dominates the European pharmaceutical logistics landscape, commanding approximately 24% of the market share in 2024. The country's prominence stems from its strategic position as Europe's largest pharmaceutical market and the fourth-largest globally. Germany's pharmaceutical logistics infrastructure is bolstered by its extensive transportation network, encompassing more than 250 inland ports, 25 international airports, and roughly 40,000 kilometers of railway tracks. The country's pharmaceutical manufacturing capabilities are supported by over 500 pharmaceutical companies, ranging from global corporations like Bayer and Boehringer Ingelheim to innovative biotech startups. The pharmaceutical logistics sector benefits from Germany's highly skilled workforce, with over 80% of workers possessing formal vocational training or university degrees. The country's commitment to pharmaceutical excellence is further demonstrated through its significant investment in research and development, particularly in areas such as biosimilars and complex biologics.
Pharmaceutical Logistics Market in Poland
Poland's pharmaceutical logistics market is experiencing remarkable growth, projected to expand at approximately 8% annually from 2024 to 2029. As Central Europe's largest pharmaceutical market and the sixth-largest in the European Union, Poland has established itself as a crucial hub for pharmaceutical distribution operations. The country's strategic geographical position facilitates efficient drug distribution networks across Eastern and Central Europe. Poland's pharmaceutical logistics infrastructure has been significantly enhanced through investments in modern warehousing facilities and transportation networks. The market's growth is driven by the country's robust healthcare system, universal healthcare coverage, and increasing focus on cost-effective pharmaceutical distribution. Poland's competitive advantage in pharmaceutical logistics is further strengthened by its lower operational costs compared to Western European countries, making it an attractive destination for international pharmaceutical companies establishing their regional distribution centers.
Pharmaceutical Logistics Market in France
France's pharmaceutical logistics market demonstrates remarkable sophistication in its infrastructure and operational capabilities. The country's strategic position in Europe's pharmaceutical landscape is reinforced by its extensive network of specialized logistics providers and state-of-the-art distribution facilities. French pharmaceutical logistics benefits from significant investments in cold chain infrastructure and technological advancement, particularly in temperature-controlled transportation and storage solutions. The market is characterized by strong collaboration between pharmaceutical manufacturers, logistics providers, and healthcare institutions, ensuring efficient drug distribution channels throughout the country. France's commitment to pharmaceutical innovation is evident in its substantial investment in research and development, with numerous logistics companies adapting their services to support clinical trials and specialized drug distribution. The country's pharmaceutical logistics sector is further strengthened by stringent quality control measures and compliance with Good Distribution Practice (GDP) guidelines.
Pharmaceutical Logistics Market in United Kingdom
The United Kingdom's pharmaceutical logistics market maintains its position as a crucial player in Europe's pharmaceutical distribution landscape. The country's pharmaceutical logistics infrastructure is characterized by its advanced cold chain capabilities and innovative distribution solutions. Post-Brexit, the UK has strengthened its pharmaceutical competitiveness through enhanced regulatory frameworks and streamlined drug evaluation methods. The market benefits from significant investments in specialized storage facilities and transportation networks, particularly around major logistics hubs. The UK's pharmaceutical logistics sector is distinguished by its focus on technological integration, including real-time tracking systems and temperature monitoring solutions. The country's strong emphasis on research and development in the pharmaceutical sector continues to drive innovations in logistics solutions, particularly in the handling of sensitive biological products and specialized medicines.
Pharmaceutical Logistics Market in Other Countries
The pharmaceutical logistics landscape across other European countries showcases diverse market dynamics and specialized capabilities. Countries like Italy, Spain, and Belgium have developed robust pharmaceutical logistics networks, each leveraging their unique geographical advantages and infrastructure capabilities. The Netherlands, with its strategic location and advanced port facilities, serves as a crucial gateway for pharmaceutical distribution across Europe. Sweden and other Nordic countries demonstrate excellence in cold chain logistics and sustainable transportation solutions. These markets are characterized by ongoing investments in modernizing logistics infrastructure, implementing digital solutions, and enhancing temperature-controlled transportation networks. The diversity of these markets contributes to the overall resilience and efficiency of Europe's pharmaceutical logistics network, with each country offering specialized services and capabilities that cater to specific regional needs and requirements.
Get Analysis on Important Geographic Markets
Download PDF
Europe Pharmaceutical Logistics Industry Overview
Top Companies in European Pharmaceutical Logistics Market
The European pharmaceutical logistics market features prominent players like DHL Supply Chain, FedEx, Kuehne + Nagel International AG, United Parcel Service, CH Robinson, CEVA Logistics, DB Schenker, and Agility Logistics, alongside regional specialists such as Eurotranspharma, CSP, and Trans-o-flex GmbH. These companies are actively investing in cold chain capabilities and temperature-controlled facilities to meet the growing demands of pharmaceutical distribution. The industry is witnessing significant technological advancement through blockchain implementation, IoT integration, and automated warehousing solutions to enhance supply chain visibility and product safety. Companies are expanding their geographical presence through strategic acquisitions and partnerships, particularly in emerging European markets. The focus on value-added services, including specialized pharmaceutical handling, regulatory compliance support, and end-to-end supply chain solutions, has become a key differentiator among market players.
Market Fragmentation Drives Strategic Consolidation Moves
The European pharmaceutical logistics market exhibits a relatively fragmented structure, characterized by the presence of both global logistics conglomerates and specialized regional players. The market's complexity is further enhanced by the diverse regulatory requirements across different European countries, creating opportunities for specialized service providers with deep local market knowledge. Major global players are leveraging their extensive networks and technological capabilities to maintain market leadership, while regional specialists are capitalizing on their expertise in specific geographic areas or specialized services. The industry has witnessed increased merger and acquisition activities, particularly focused on expanding cold chain capabilities and technological infrastructure.
The competitive dynamics are shaped by the increasing trend of pharmaceutical companies outsourcing their logistics operations to focus on core competencies. This has led to the emergence of integrated service providers offering end-to-end solutions, from pharmaceutical warehousing to last-mile pharmaceutical delivery. The market has seen significant investments in specialized infrastructure, particularly in key pharmaceutical manufacturing hubs across Germany, Switzerland, and other Western European countries. Companies are increasingly focusing on developing dedicated pharmaceutical logistics networks, with specialized handling capabilities and GDP-compliant facilities.
Innovation and Compliance Drive Market Success
Success in the European pharmaceutical logistics market increasingly depends on the ability to provide innovative, technology-driven solutions while maintaining strict compliance with regulatory requirements. Companies that can offer integrated digital platforms, real-time tracking capabilities, and temperature-controlled solutions are better positioned to capture market share. The development of specialized expertise in handling different types of pharmaceutical products, from traditional medicines to biologics and vaccines, has become crucial for market success. Investment in sustainable practices and green logistics solutions is emerging as a key differentiator, particularly in environmentally conscious European markets.
Market contenders can gain ground by focusing on niche segments or specific geographic regions where they can build specialized capabilities and strong customer relationships. The increasing adoption of e-commerce in the pharmaceutical sector presents opportunities for logistics providers to develop specialized last-mile delivery solutions. Success also depends on building strong partnerships with pharmaceutical manufacturers and maintaining high service quality standards. Companies must navigate the complex regulatory landscape while investing in risk management capabilities and maintaining flexibility to adapt to changing market conditions. The ability to provide value-added services and customize solutions according to specific client needs will continue to be crucial for maintaining competitive advantage.
Europe Pharmaceutical Logistics Market Leaders
-
DHL
-
FedEx
-
Kuehne + Nagel International AG
-
United Parcel Service
-
C. H. Robinson
- *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF
Europe Pharmaceutical Logistics Market News
January 2024: Nippon Express obtained CEIV Pharma certification, a quality certification for pharmaceutical transport established by the International Air Transport Association IATA for its warehouse at Schiphol Trade Park, near Amsterdam Airport Schiphol in the Netherlands. In order to meet the various needs of the pharmaceutical logistics sector, the NX Group is working toward developing a worldwide platform for the safety and security of medicinal products.
October 2023: UPS Healthcare announced the opening of UPS Pickup Points, a new reverse logistics service for healthcare laboratory customers in the UK, Italy, Germany, France, and Spain. The Pickup Points were intended to tackle the challenges posed by healthcare logistics, which were associated with the increase in new drug development. Samples were taken from a variety of locations and time intervals by many healthcare facilities.
Europe Pharmaceutical Logistics Industry Segmentation
Pharmaceutical logistics is related to the handling, transport, and chain management of multiple and varied products that require specific standards in their logistic treatment. Pharmaceutical products range from medicines and all their typologies, healthcare products, and medical and surgical instruments to cosmetic and perfume products, raw materials, biotechnological materials, and biopharmaceuticals.
A complete background analysis of the European pharmaceutical logistics market, including the assessment of the economy and contribution of sectors in the economy, market overview, market size estimation for key segments, emerging trends in the segments, market dynamics, geographical trends, and COVID-19 impact, is covered in the report.
The European pharmaceutical logistics market is segmented by product (generic drugs and branded drugs), operation (cold chain transport and non-cold chain transport), application (biopharma and chemical pharma), transport (airways, railways, roadways, and seaways), and geography (Germany, the United Kingdom, the Netherlands, France, Italy, Spain, Poland, Belgium, Sweden, and Rest of Europe). The report offers market sizes and forecasts for all the above segments in value (USD).
| By Product | Generic Drugs |
| Branded Drugs | |
| By Operation | Cold Chain Transport |
| Non-cold Chain Transport | |
| By Application | Biopharma |
| Chemical Pharma | |
| By Transportation | Airways |
| Railways | |
| Roadways | |
| Seaways | |
| By Geography | Germany |
| United Kingdom | |
| The Netherlands | |
| France | |
| Italy | |
| Spain | |
| Poland | |
| Belgium | |
| Sweden | |
| Rest of Europe |
By Product
| Generic Drugs |
| Branded Drugs |
By Operation
| Cold Chain Transport |
| Non-cold Chain Transport |
By Application
| Biopharma |
| Chemical Pharma |
By Transportation
| Airways |
| Railways |
| Roadways |
| Seaways |
By Geography
| Germany |
| United Kingdom |
| The Netherlands |
| France |
| Italy |
| Spain |
| Poland |
| Belgium |
| Sweden |
| Rest of Europe |
Need A Different Region or Segment?
Customize Now
Europe Pharmaceutical Logistics Market Research Faqs
How big is the Europe Pharmaceutical Logistics Market?
The Europe Pharmaceutical Logistics Market size is expected to reach USD 90.30 billion in 2025 and grow at a CAGR of 3.92% to reach USD 109.44 billion by 2030.
What is the current Europe Pharmaceutical Logistics Market size?
In 2025, the Europe Pharmaceutical Logistics Market size is expected to reach USD 90.30 billion.
Who are the key players in Europe Pharmaceutical Logistics Market?
DHL, FedEx, Kuehne + Nagel International AG, United Parcel Service and C. H. Robinson are the major companies operating in the Europe Pharmaceutical Logistics Market.
What years does this Europe Pharmaceutical Logistics Market cover, and what was the market size in 2024?
In 2024, the Europe Pharmaceutical Logistics Market size was estimated at USD 86.76 billion. The report covers the Europe Pharmaceutical Logistics Market historical market size for years: 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Pharmaceutical Logistics Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
